Handling sensitive patient data is a critical responsibility for organizations involved in clinical trials. To meet regulatory requirements, many rely on SDTM mapping—a process that converts raw ...
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurements RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a ...
Certara, Inc., a global leader in biosimulation, announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical and statistical programmers to efficiently create, reuse, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results